LSE - Delayed Quote GBp
Fusion Antibodies plc (FAB.L)
6.80
-0.68
(-9.09%)
At close: April 25 at 6:32:20 PM GMT+1
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-1,769
-1,769
-1,754
-330
-1,136
Investing Cash Flow
1
1
-111
-257
-362
Financing Cash Flow
2,770
2,770
3
-55
2,647
End Cash Position
1,199
1,199
195
2,049
2,686
Capital Expenditure
-2
-2
-114
-258
-365
Issuance of Capital Stock
2,808
2,808
--
116
2,815
Issuance of Debt
--
--
69
--
14
Repayment of Debt
-33
-33
-62
-162
-164
Free Cash Flow
-1,771
-1,771
-1,868
-588
-1,501
3/31/2021 - 12/18/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2QV0.F Chemomab Therapeutics Ltd.
1.0900
+2.83%
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
6XY.F HBM Holdings Limited
0.9000
+5.88%
TRMED.OL Thor Medical ASA
2.4000
-2.24%
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
TRX.L Tissue Regenix Group plc
35.00
+0.57%
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
MEDCL.PA MedinCell S.A.
14.97
+0.13%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%